A de Lorenzo, C Bernis, G Diego, J A Sánchez Tomero. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AgedAnti-Bacterial Agents/therapeutic useBacteremia/drug therapyBacteremia/etiologyCatheters, Indwelling/adverse effectsDiabetes Complications/drug therapyDiabetes Complications/etiologyDiabetes Complications/microbiologyDiscitis/drug therapyDiscitis/etiologyDiscitis/microbiologyEndocarditis, Bacterial/drug therapyEndocarditis, Bacterial/epidemiologyEndocarditis, Bacterial/etiologyEndocarditis, Bacterial/microbiologyFever/etiologyHeart Valve ProsthesisHumansHyperparathyroidism, Secondary/complicationsIncidenceKidney Failure, Chronic/complicationsKidney Failure, Chronic/therapyLumbar VertebraeMethicillin ResistancePrognosisRenal DialysisRifampin/therapeutic useSpain/epidemiologyStaphylococcal Infections/drug therapyStaphylococcal Infections/epidemiologyStaphylococcal Infections/etiologyStaphylococcus aureus/drug effectsStaphylococcus aureus/isolation & purificationVancomycin/therapeutic use
Substances： See more » Anti-Bacterial AgentsVancomycinRifampin
Year: 2006 PMID： 17227258
Source DB: PubMed Journal: Nefrologia ISSN： 0211-6995 Impact factor: 2.033